Intravenous antibiotics for urinary tract infections in children with neurologic impairment
Lauren S. Starnes(Vanderbilt University Medical Center), Katherine L. Freundlich(Vanderbilt University Medical Center), Douglass B. Clayton(Vanderbilt University Medical Center), Derek J. Williams, Charlotte M. Brown(Vanderbilt University Medical Center), My‐Linh Ngo(Vanderbilt University Medical Center), Matt Hall(Child Health Corporation of America), Alison R. Carroll(Monroe Carell Jr. Children's Hospital), Sophie E. Katz(Vanderbilt University Medical Center), Alison Herndon(Vanderbilt University Medical Center), James W. Antoon(Vanderbilt University Medical Center), Ryan Wolf(Wake Forest University), Deanna S. Bell, Kelsey A.B. Gastineau(Monroe Carell Jr. Children's Hospital)
Cited by 3
Related Papers
Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640
|Endocrinology|2010|114
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease
|Journal of the American College of Cardiology|2022|59
Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer
|Journal of Molecular Endocrinology|2011|49
Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance
|Scientific Reports|2012|37